Applied Therapeutics, Inc. — Director's Dealing 2022

Aug 5, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Applied Therapeutics Inc. (APLT)
CIK: 0001697532
Period of Report: 2022-08-02

Reporting Person: Hansard Adam (Chief Commercial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-08-02	Employee Stock Option (Right to Buy)	$2.02	D	50000	Disposed	2032-04-13	Common Stock (50000)	Direct
2022-08-02	Employee Stock Option (Right to Buy)	$1.05	D	50000	Acquired	2032-04-13	Common Stock (50000)	Direct
2022-08-02	Employee Stock Option (Right to Buy)	$4.17	D	21100	Disposed	2032-01-07	Common Stock (21100)	Direct
2022-08-02	Employee Stock Option (Right to Buy)	$1.05	D	21100	Acquired	2032-01-07	Common Stock (21100)	Direct
2022-08-02	Employee Stock Option (Right to Buy)	$9.44	D	21100	Disposed	2031-12-14	Common Stock (21100)	Direct
2022-08-02	Employee Stock Option (Right to Buy)	$1.05	D	21100	Acquired	2031-12-14	Common Stock (21100)	Direct
2022-08-02	Employee Stock Option (Right to Buy)	$23.15	D	32339	Disposed	2030-12-10	Common Stock (32339)	Direct
2022-08-02	Employee Stock Option (Right to Buy)	$1.05	D	32339	Acquired	2030-12-10	Common Stock (32339)	Direct
2022-08-02	Employee Stock Option (Right to Buy)	$34.28	D	104665	Disposed	2030-03-09	Common Stock (104665)	Direct
2022-08-02	Employee Stock Option (Right to Buy)	$1.05	D	104665	Acquired	2030-03-09	Common Stock (104665)	Direct

Footnotes

F1: The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options.

F2: Reflects an initial grant of 50,000 Options granted on April 13, 2022 that vests as follows: One-fourth (1/4th) of the shares subject to the compensatory Option shall vest on April 13, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.

F3: Reflects an initial grant of 21,100 Options granted on January 7, 2022 that vests as follows: One-fourth (1/4th) of the shares subject to the compensatory Option shall vest on January 7, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.

F4: Reflects an initial grant of 21,100 Options granted on December 14, 2021 that vests as follows: One-fourth (1/4th) of the shares subject to the compensatory Option shall vest on December 14, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.

F5: Reflects an initial grant of 81,700 Options granted on March 9, 2020 that vests as follows: One-fourth (1/4th) of the shares subject to the Option shall vest on December 10, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.

F6: Reflects an initial grant of 179,425 Options granted on March 9, 2020 that vests as follows: One-fourth (1/4th) of the shares subject to the Option shall vest on March 9, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.